Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

TocopheRx divulges FSH-R agonists

Jan. 19, 2016

Shanghai Hengrui Pharmaceutical presents hURAT1 inhibitor

Jan. 19, 2016

Grant supports Evestra's research into long-acting injectable fertility control

Jan. 19, 2016

Hinova Pharmaceuticals patents potential treatments for gout

Jan. 18, 2016

BMPR1B-Fc chimera shows bone-increasing effects without toxicity

Jan. 15, 2016

ONO submits a manufacturing and marketing approval application for ONO-5163 in Japan

Jan. 15, 2016

Kowa plans cardiovascular outcomes trial of K-877

Jan. 15, 2016

Novel FXR agonist demonstrates preclinical efficacy for dyslipidemia

Jan. 14, 2016

The Medicines Company starts phase II trial of ALN-PCSsc

Jan. 13, 2016

Abeona receives initial clearance for clinical trials of Sanfilippo syndrome gene therapies

Jan. 13, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...